Debora Malpicci
Magna Graecia University · 21 works · 602 citations · h-index 9
Top works
- Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
- miR-579-3p controls melanoma progression and resistance to target therapy
- MicroRNAs in melanoma development and resistance to target therapy
- Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
- Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
- Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
- ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin
- Melanoma and immunotherapy bridge 2015
- ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
- Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
- Abstract 1070: miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma
- Abstract 4230: Targeting lung cancer stem cells through fatty acid metabolism
- MicroRNAs regulate resistance to target therapy in melanoma